Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.
NCT04904523 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-05-27
Summary
Corona Virus Disease or COVID-19 is caused by SARS-CoV-2 virus. There have been reports of serious COVID-19 illness in children. In addition it has been linked to clusters of children presenting with high fevers and inflammation.
Sepsis, also called blood poisoning, is an abnormal response of the body to some infections. We aim to conduct research in children under 18 admitted to intensive care unit.
Using a systems approach towards mapping the body's immune and metabolic responses to COVID-19 or related illnesses and compare with other sepsis like illnesses.
Conditions
- Covid19
- Sepsis
Interventions
- DIAGNOSTIC_TEST
-
Diagnostic Test:Blood test
Drop of blood for RNA and metabolic analysis
Sponsors & Collaborators
-
Cardiff and Vale University Health Board
collaborator OTHER_GOV -
Cardiff University
lead OTHER
Eligibility
- Min Age
- 1 Day
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-16
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Algorithm for Predicting the Unfavorable Course of Sepsis in Children
NCT05908162 ·Status: COMPLETED
-
Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis
NCT05589909 ·Status: UNKNOWN
-
Prognostic Value of Complete Blood Count in Severe Infections
NCT03685071 ·Status: UNKNOWN
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure
NCT04422626 ·Status: WITHDRAWN
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
NCT01998139 ·Status: COMPLETED
-
Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis
NCT04103268 ·Status: RECRUITING
-
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
NCT04049565 ·Status: COMPLETED
-
Modulation of Molecular Fingerprinting in Pediatric Sepsis
NCT02055105 ·Status: RECRUITING
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING
-
Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot Study
NCT00732277 ·Status: COMPLETED ·Phase: PHASE2
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
NCT04794595 ·Status: RECRUITING
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis
NCT02544490 ·Status: COMPLETED
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Coagulation Disturbances in COVID-19 Septic Patients
NCT05496816 ·Status: COMPLETED
-
A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children
NCT04955210 ·Status: RECRUITING
-
Procalcitonin in Diagnosis of Bacterial Infections in Young Infants
NCT03509727 ·Status: COMPLETED
-
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
NCT05692128 ·Status: UNKNOWN
-
Diagnostic Performance of a New Bio-marker During Bacterial Sepsis
NCT02721134 ·Status: COMPLETED ·Phase: NA
-
A Machine Learning Predictive Model for Sepsis
NCT04771429 ·Status: UNKNOWN